Chonluten (10 mg Vial) Dosage Protocol
Chonluten is a synthetic tripeptide bioregulator (Glu-Asp-Gly) targeting pulmonary tissue. Studied in Russian protocols for chronic lung conditions.
⚡ Quickstart Highlights
Dosing & Reconstitution Guide
Route: Subcutaneous | Frequency: Daily during cycle | Half-life: Short; cumulative effect
Standard Approach (3 mL = 3.33 mg/mL)
Reconstituting with 3 mL bacteriostatic water produces a concentration of 3.33 mg/mL. Volume per dose changes with concentration; mg dose itself does not change between vial sizes.
| Phase / Protocol | Dose | U-100 Units | Volume | Doses per vial |
|---|---|---|---|---|
| Cycle | 300 mcg | 9 units | 0.090 mL | 33 doses |
Reconstitution Steps
- Wipe the vial stopper and BAC water vial with alcohol; let dry.
- Draw 3 mL of bacteriostatic water into a sterile syringe.
- Inject slowly down the inside glass wall of the peptide vial. Do not aim at the powder.
- Gently swirl until fully dissolved. Do not shake.
- Label with reconstitution date. Refrigerate at 2–8°C; use within 30 days.
Supplies Needed
Estimates for an 8-week and 12-week cycle at 300 mcg per dose, daily during cycle (7 doses/week).
| Item | 8-Week Cycle | 12-Week Cycle |
|---|---|---|
| Chonluten (10 mg) vials | 2 vials | 3 vials |
| Insulin syringes (U-100) | 56 | 84 |
| Bacteriostatic water (10 mL) | 1 × 10 mL | 1 × 10 mL |
| Alcohol swabs | 1 × 100-pack | 2 × 100-pack |
Protocol Overview
This peptide bioregulator follows the standard Khavinson-class cycle protocol — 10–20 day intensive cycles, 1–2 times per year. The hypothesized gene-expression mechanism produces effects that persist months after the cycle ends, supporting the cycled rather than continuous approach.
Dosing Protocol
Cycle-based dosing:
- Standard cycle: Daily dose during 10–20 day active phase, 5–6 month break.
Cycle structure: 1–2 cycles per year. Some users align cycles with seasonal transitions.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | −20°C (−4°F) | Up to 24 months, dry & dark |
| Reconstituted | 2–8°C (35–46°F) | Up to 30 days, protect from light |
Important Notes
How This Works
Chonluten is a Khavinson tetrapeptide bioregulator targeting lung tissue gene expression and supporting alveolar function in animal models of chronic respiratory disease.
Potential Benefits & Side Effects
Potential Benefits
- Studied in COPD and chronic bronchitis support.
- Anti-inflammatory effects in airway tissue.
Side Effect Profile
- Generally well-tolerated.
- Mild injection-site reactions.
Lifestyle Factors
- Smoking cessation, hydration, adequate sleep.
Injection Technique
- Subcutaneous, rotate sites during cycle.